There have been developments in LASIK surgery that have improved outcomes for patients. George O. Waring, IV, MD, founder and medical director of the Waring Vision Institute, discussed how new technology works with high repetition rates and advanced features that result in statistically significant improvements in contrast sensitivity after LASIK.

“We saw more patients achieve best-corrected vision by a factor of three,” he said of the Technolas Teneo 317 Model 2.

Additionally, Waring highlighted the laser's unique ability to not require a nomogram, minimizing the risk of human error during treatment. The laser has demonstrated exceptional results in a variety of vision correction procedures, achieving an R-squared value of 0.98, indicating a near-perfect match between intended and actual results.

He also discussed the latest OmniVu data, noting promising long-term refractive stability over two years.

“This is truly a more physiological lens, meaning that because it fills the capsule, we don't see subtle shifts in the effect of lens position,” Waring said. “If we stabilize the lens capsule and capsule forces in a more physiological way, we believe this answers one of the last unanswered possibilities in modern refractive cataract surgery, namely the elusive effective lens position.”